EE04095B1 - Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks - Google Patents

Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks

Info

Publication number
EE04095B1
EE04095B1 EEP200000244A EEP200000244A EE04095B1 EE 04095 B1 EE04095 B1 EE 04095B1 EE P200000244 A EEP200000244 A EE P200000244A EE P200000244 A EEP200000244 A EE P200000244A EE 04095 B1 EE04095 B1 EE 04095B1
Authority
EE
Estonia
Prior art keywords
ketolides
preparation
pharmaceutically acceptable
pharmaceutical compositions
acceptable salts
Prior art date
Application number
EEP200000244A
Other languages
English (en)
Estonian (et)
Inventor
Petit Francis
Vacheron Fran�oise
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of EE200000244A publication Critical patent/EE200000244A/xx
Publication of EE04095B1 publication Critical patent/EE04095B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
EEP200000244A 1997-11-17 1998-11-16 Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks EE04095B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (2)

Publication Number Publication Date
EE200000244A EE200000244A (et) 2001-06-15
EE04095B1 true EE04095B1 (et) 2003-08-15

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000244A EE04095B1 (et) 1997-11-17 1998-11-16 Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks

Country Status (35)

Country Link
US (1) US20080139489A1 (es)
EP (1) EP1030673B1 (es)
JP (1) JP4550273B2 (es)
KR (1) KR20010032130A (es)
CN (1) CN1286633A (es)
AP (1) AP1196A (es)
AR (1) AR014119A1 (es)
AT (1) ATE271875T1 (es)
AU (1) AU744419B2 (es)
BG (1) BG104427A (es)
BR (1) BR9814199A (es)
CA (1) CA2312021C (es)
DE (1) DE69825308T2 (es)
DZ (1) DZ2654A1 (es)
EA (1) EA003322B1 (es)
EE (1) EE04095B1 (es)
ES (1) ES2224446T3 (es)
FR (1) FR2771008B1 (es)
GE (1) GEP20032968B (es)
HR (1) HRP20000314A2 (es)
HU (1) HUP0004507A3 (es)
ID (1) ID24940A (es)
IL (1) IL136149A0 (es)
MA (1) MA26566A1 (es)
NO (1) NO20002435L (es)
NZ (1) NZ504305A (es)
OA (1) OA11411A (es)
PL (1) PL340373A1 (es)
SK (1) SK7042000A3 (es)
TN (1) TNSN98206A1 (es)
TR (1) TR200001384T2 (es)
TW (1) TW472061B (es)
WO (1) WO1999025365A1 (es)
YU (1) YU29600A (es)
ZA (1) ZA9810357B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ES2273964T3 (es) * 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
ID30233A (id) * 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
HUP0300370A3 (en) 2000-04-04 2005-07-28 Smithkline Beecham Plc 2-hydroxy-mutilin carbamate derivatives of antibacterial effect process for preparation and pharmaceutical compositions containing them
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
JP6042334B2 (ja) * 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
EP1030673B1 (fr) 2004-07-28
KR20010032130A (ko) 2001-04-16
NO20002435D0 (no) 2000-05-11
CN1286633A (zh) 2001-03-07
YU29600A (sh) 2003-02-28
AR014119A1 (es) 2001-02-07
EA003322B1 (ru) 2003-04-24
CA2312021C (fr) 2008-08-26
GEP20032968B (en) 2003-05-27
FR2771008B1 (fr) 2000-04-28
AP2000001825A0 (en) 2000-06-30
AU744419B2 (en) 2002-02-21
EE200000244A (et) 2001-06-15
BG104427A (en) 2001-02-28
SK7042000A3 (en) 2000-12-11
IL136149A0 (en) 2001-05-20
NO20002435L (no) 2000-07-07
EA200000531A1 (ru) 2000-10-30
US20080139489A1 (en) 2008-06-12
DE69825308T2 (de) 2005-08-04
BR9814199A (pt) 2000-09-26
ATE271875T1 (de) 2004-08-15
TW472061B (en) 2002-01-11
ES2224446T3 (es) 2005-03-01
NZ504305A (en) 2002-11-26
FR2771008A1 (fr) 1999-05-21
HUP0004507A3 (en) 2001-12-28
JP2001523644A (ja) 2001-11-27
TR200001384T2 (tr) 2001-06-21
MA26566A1 (fr) 2004-12-20
TNSN98206A1 (fr) 2005-03-15
ZA9810357B (en) 1999-11-12
AU1242599A (en) 1999-06-07
EP1030673A1 (fr) 2000-08-30
JP4550273B2 (ja) 2010-09-22
HUP0004507A1 (hu) 2001-05-28
WO1999025365A1 (fr) 1999-05-27
DZ2654A1 (fr) 2003-03-22
CA2312021A1 (fr) 1999-05-27
DE69825308D1 (de) 2004-09-02
HRP20000314A2 (en) 2001-02-28
PL340373A1 (en) 2001-01-29
AP1196A (en) 2003-08-18
ID24940A (id) 2000-08-31
OA11411A (fr) 2004-04-20

Similar Documents

Publication Publication Date Title
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
NO20003218D0 (no) Oralfarmasøytisk doseringsform med forlenget frigivningsvirkning
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
IS5245A (is) Lyfjablanda úr ómeprasól
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
NO975831D0 (no) Nytt farmasöytisk preparat med anestetisk virkning
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
IL139512A0 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
BR0012184B1 (pt) compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
NO992999D0 (no) Farmas°ytisk blanding for oral administrering
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20041116